Key result
Dipyridamole stress testing triggers STEMI refractory to aminophylline in a rare case report.
Why the study?
Myocardial ischaemia and rare ST-elevation myocardial infarction can occur during dipyridamole stress testing, but the underlying mechanisms beyond coronary steal remain unclear.
Case Report (n=1)
Rare STEMI risk during dipyridamole testing despite aminophylline warrants vigilance; leaves open optimal patient selection and reversal strategies.
BACKGROUND: Dipyridamole stress is commonly used for myocardial perfusion imaging and is generally safe. Myocardial ischaemia can occasionally occur and is classically thought to be due to coronary steal as a result of redistribution of flow away from collateral dependent myocardium. Although ischaemia more commonly presents as electrocardiographic (ECG) ST depression and angina, ST-elevation myocardial infarction may occur as a very rare complication. CASE SUMMARY: We report a case of a patient who developed chest pain and ST depression during dipyridamole infusion. The pain persisted despite intravenous aminophylline with new inferior ST elevation soon after. Coronary angiography showed subtotal right coronary artery occlusion with no collateral supply. The symptoms and ECG changes resolved after percutaneous coronary intervention. DISCUSSION: Coronary steal may not fully account for our patient's presentation given the failure of aminophylline and absent angiographic collaterals. Vasospasm may be triggered by dipyridamole and can directly cause ischaemia or provoke rupture of an unstable plaque. Augmentation of cardiac energetics during vasodilator stress may also play a role.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) conducted a case report in Myocardial ischemia and ST-elevation myocardial infarction (n=1). Dipyridamole was evaluated on Development of ST-elevation myocardial infarction during stress testing. Dipyridamole stress testing induced ST-segment depression that progressed to ST-elevation myocardial infarction despite intravenous aminophylline in a 67-year-old woman.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: